The acute uveitisphase of VKH is usually responsive to high-dose oral corticosteroids; parenteral administration is usually not required. However, ocular complications may require a subtenon or intravitreous injection of corticosteroids or bevacizumab. In refractory situations, other immunosuppressives such as cyclosporine, or tacrolimus, antimetabolites (azathioprine, mycophenolate mofetil or methotrexate), or biological agents such as intravenous immunoglobulins (IVIG) or infliximab may be needed.
Vogt–Koyanagi–Harada disease
Marchiafava–Bignami disease
Pogosta disease
Galli–Galli disease
Cortes Lacassie syndrome
Itai-itai disease
Machado–Joseph disease
Franceschetti–Klein syndrome